MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-DL-08-0013986
Redvaxin Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹10.21 Cr
▲ 199% YoY
Net profit · FY 2024
₹32.67 Lakh
Net margin 3.2%
EBITDA · FY 2024
₹54.07 Lakh
EBITDA margin 5.3%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹2.78 Lakh
Issued & subscribed
Open charges
₹2 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
5
As per MCA filings
About Redvaxin Private Limited
Data last updated:
Redvaxin Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U21001DL2020PTC365992. Its GSTIN is 07AAKCR2616J1Z8 (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2.78 Lakh. It is led by directors including Aparna Rajput and Rakesh Sharma.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Su – 21 Dda Building Madam Bhika Cama Place Bhawan, 11 Bhikaji Cama Place, New Delhi, Delhi, India – 110066.
As per the financials filed for FY 2024, the company reported a revenue of ₹10.21 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹32.67 Lakh (net margin 3.2%) and EBITDA of ₹54.07 Lakh (EBITDA margin 5.3%).
As per MCA filings, the company has open charges of ₹2 Cr on record.
Redvaxin Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-DL-08-0013986). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website redvaxin.com.
Company details
CIN U21001DL2020PTC365992
Registration Number 365992
Incorporation Date 12 July 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-DL-08-0013986
CIN history
Redvaxin has one previous CIN (Corporate Identification Number): U24230DL2020PTC365992. The current CIN is U21001DL2020PTC365992, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U21001DL2020PTC365992 | Current |
| U24230DL2020PTC365992 | Previous |
Recognitions & Rankings of Redvaxin
Contact details
Redvaxin Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressSu – 21 Dda Building Madam Bhika Cama Place Bhawan, 11 Bhikaji Cama Place, New Delhi, Delhi, India – 110066
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Redvaxin Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Redvaxin is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Redvaxin Private Limited, buy the company report.
Financials of Redvaxin Private Limited
FY 2024 filings availableRedvaxin Private Limited reported revenue of ₹10.21 Cr (up 199% YoY) for FY 2024.
Revenue · FY 2024
₹10.21 Cr ▲ 199%
Net profit · FY 2024
₹32.67 Lakh margin 3.2%
EBITDA · FY 2024
₹54.07 Lakh margin 5.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 199%
EBITDA CAGR growth
1 year
▲ 156%
3 years · compounded
▲ 246%
Revenue rose 199% in the latest year. EBITDA rose 156% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹54.07 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹32.67 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 5.3% | |||
| Net Profit Margin | 3.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Redvaxin Private Limited, buy the company report.
Board of directors of Redvaxin Private Limited
Redvaxin has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sushil Kumar Also directs: Supritech Solutions Private Limited | Additional Director | 16 Jun 2025 | 1 Years 4 Months | Current |
| Aparna Rajput Also directs: Supritech Solutions Private Limited, Redvaxin (I) Private Limited | Director | 12 Jul 2020 | 6 Years 3 Months | Current |
| Rakesh Sharma | Director | 12 Jul 2020 | 6 Years 3 Months | Current |
| Usha Rani | Additional Director | 16 Jun 2025 | 1 Years 4 Months | Current |
| Amit Kumar Luthra | Additional Director | 16 Jun 2025 | 1 Years 4 Months | Current |
Charges & borrowings
Open charges
₹2 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Dec 2024 | 101023477 | Others | ₹2 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Redvaxin Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Redvaxin Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Redvaxin has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAKCR2616J1Z8 | Delhi | Active | 01 Mar 2021 |
| 05AAKCR2616J1ZC | Uttarakhand | Active | 09 Feb 2022 |
To see the full GST registrations and return filing status of Redvaxin Private Limited, buy the company report.
Recent activity
Redvaxin Private Limited has 6 board changes on record since 2020: 5 appointments and 1 cessation. The latest: Amit Kumar Luthra was appointed as Additional Director on 16 Jun 2025.
Appointed
Amit Kumar Luthra was appointed as Additional Director.
Appointed
Sushil Kumar was appointed as Additional Director.
Appointed
Usha Rani was appointed as Additional Director.
Charges
A charge with Others amounted to Rs. 200.00 Lakh with Charge ID 101023477 was registered on 13 Dec 2024.
AGM
Redvaxin Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Redvaxin Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Ceased
Uttam Shivaji Kale ceased to be Additional Director.
Appointed
Aparna Rajput was appointed as Director.
Appointed
Rakesh Sharma was appointed as Director.
Incorporation
12 Jul 2020
Redvaxin Private Limited was registered on 12 Jul 2020 with Roc Delhi & aged 6 years 3 months as per MCA records.
Frequently asked questions
Redvaxin is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 July 2020 (6+ years old) and is registered under CIN U21001DL2020PTC365992.
Redvaxin has 5 current directors:
- Sushil Kumar - Additional Director
- Aparna Rajput - Director
- Rakesh Sharma - Director
- Usha Rani - Additional Director
- Amit Kumar Luthra - Additional Director
The latest financial statements of Redvaxin on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Redvaxin is 07AAKCR2616J1Z8, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 05AAKCR2616J1ZC (Uttarakhand).
The CIN (Corporate Identification Number) of Redvaxin is U21001DL2020PTC365992. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Redvaxin was incorporated on 12 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Amit Kumar Luthra was appointed as Additional Director on 16 Jun 2025. Sushil Kumar was appointed as Additional Director on 16 Jun 2025. Usha Rani was appointed as Additional Director on 16 Jun 2025. Redvaxin has 6 board changes on record in total.
Yes, Redvaxin is registered as an MSME under Udyam registration (number: UDYAM-DL-08-0013986).
Redvaxin can be reached through the website redvaxin.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Redvaxin is at Su – 21 Dda Building Madam Bhika Cama Place Bhawan, 11 Bhikaji Cama Place, New Delhi, Delhi, India – 110066.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages